International audienceBackground: Animal venoms are large, complex libraries of bioactive, disulphide-rich peptides. These peptides, and their novel biological activities, are of increasing pharmacological and therapeutic importance. However, recombinant expression of venom peptides in Escherichia coli remains difficult due to the significant number of cysteine residues requiring effective post-translational processing. There is also an urgent need to develop high-throughput recombinant protocols applicable to the production of reticulated peptides to enable efficient screening of their drug potential. Here, a comprehensive study was developed to investigate how synthetic gene design, choice of fusion tag, compartment of expression, tag rem...
Thesis (Master's)--University of Washington, 2018The objective of this study is to identify the best...
Escherichia coli (E. coli) is the most widely used expression system for the production of recombina...
Bioactive venom peptides are increasingly being explored as drug leads in pharmaceutical research be...
Background: Animal venoms are large, complex libraries of bioactive, disulphide-rich peptides. These...
Background: Animal venoms are complex molecular cocktails containing a wide range of biologically ac...
High-throughput production (HTP) of synthetic genes is becoming an important tool to explore the bio...
Proteins are now widely produced in diverse microbial cell factories. The Escherichia coli is still ...
<div><p>Commercial uses of bioactive peptides require low cost, effective methods for their producti...
Commercial uses of bioactive peptides require low cost, effective methods for their production. We d...
<p>Venom peptides with molecular weight (MW) ranging from 2000–8000 Da and with 2–6 disulfide (SS) b...
International audienceBackgroundGene synthesis is becoming an important tool in many fields of recom...
From PubMed via Jisc Publications RouterHistory: received 2021-04-28, revised 2021-06-02, accepted 2...
ReviewInternational audienceBackground: venoms of a variety of animal species (i.e. scorpions, snake...
Animal venoms are complex chemical arsenals. Most venoms are rich in bioactive peptides with proven ...
Thesis (Master's)--University of Washington, 2018The objective of this study is to identify the best...
Escherichia coli (E. coli) is the most widely used expression system for the production of recombina...
Bioactive venom peptides are increasingly being explored as drug leads in pharmaceutical research be...
Background: Animal venoms are large, complex libraries of bioactive, disulphide-rich peptides. These...
Background: Animal venoms are complex molecular cocktails containing a wide range of biologically ac...
High-throughput production (HTP) of synthetic genes is becoming an important tool to explore the bio...
Proteins are now widely produced in diverse microbial cell factories. The Escherichia coli is still ...
<div><p>Commercial uses of bioactive peptides require low cost, effective methods for their producti...
Commercial uses of bioactive peptides require low cost, effective methods for their production. We d...
<p>Venom peptides with molecular weight (MW) ranging from 2000–8000 Da and with 2–6 disulfide (SS) b...
International audienceBackgroundGene synthesis is becoming an important tool in many fields of recom...
From PubMed via Jisc Publications RouterHistory: received 2021-04-28, revised 2021-06-02, accepted 2...
ReviewInternational audienceBackground: venoms of a variety of animal species (i.e. scorpions, snake...
Animal venoms are complex chemical arsenals. Most venoms are rich in bioactive peptides with proven ...
Thesis (Master's)--University of Washington, 2018The objective of this study is to identify the best...
Escherichia coli (E. coli) is the most widely used expression system for the production of recombina...
Bioactive venom peptides are increasingly being explored as drug leads in pharmaceutical research be...